speb/financial-data huggingface dataset:
PETS balance_sheet (annual, 2023-03-31) — Dividends Payable: 1262000.00
PETS income_statement (annual, 2023-03-31) — EBIT: 6051000.00
PETS income_statement (annual, 2023-03-31) — EBITDA: 9597000.00
PETS cash_flow (annual, 2023-03-31) — End Cash Position: 104086000.00
PETS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -24537000.00
PETS balance_sheet (annual, 2023-03-31) — Finished Goods: 19023000.00
PETS cash_flow (annual, 2023-03-31) — Free Cash Flow: 22543000.00
PETS income_statement (annual, 2023-03-31) — General And Administrative Expense: 41714000.00
PETS balance_sheet (annual, 2023-03-31) — Goodwill: 0.00
PETS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 860000.00
PETS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1775000.00
PETS balance_sheet (annual, 2023-03-31) — Gross PPE: 41409000.00
PETS income_statement (annual, 2023-03-31) — Gross Profit: 76501000.00
PETS cash_flow (annual, 2023-03-31) — Income Tax Paid Supplemental Data: 4312000.00
PETS income_statement (annual, 2023-03-31) — Interest Income: 450000.00
PETS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 450000.00
PETS balance_sheet (annual, 2023-03-31) — Inventory: 19023000.00
PETS balance_sheet (annual, 2023-03-31) — Invested Capital: 109957000.00
PETS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -10260000.00
PETS balance_sheet (annual, 2023-03-31) — Investments And Advances: 5000000.00
PETS balance_sheet (annual, 2023-03-31) — Land And Improvements: 3700000.00
PETS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 0.00
PETS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
PETS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 18795000.00
PETS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -5000000.00
PETS income_statement (annual, 2023-03-31) — Net Income: 5140000.00
PETS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 5140000.00
PETS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 5140000.00
PETS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 5140000.00
PETS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 5140000.00
PETS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 5140000.00
PETS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 5140000.00
PETS income_statement (annual, 2023-03-31) — Net Interest Income: 450000.00
PETS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 450000.00
PETS balance_sheet (annual, 2023-03-31) — Net PPE: 26178000.00
PETS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -5260000.00
PETS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 109106000.00
PETS balance_sheet (annual, 2023-03-31) — Non Current Deferred Assets: 5009000.00
PETS balance_sheet (annual, 2023-03-31) — Non Current Deferred Liabilities: 0.00
PETS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 5009000.00
PETS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 0.00
PETS income_statement (annual, 2023-03-31) — Normalized EBITDA: 9597000.00
PETS income_statement (annual, 2023-03-31) — Normalized Income: 5140000.00
PETS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 27803000.00
PETS income_statement (annual, 2023-03-31) — Operating Income: 6051000.00
PETS income_statement (annual, 2023-03-31) — Operating Revenue: 247569000.00
PETS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 21084277.00
PETS balance_sheet (annual, 2023-03-31) — Other Current Assets: 4719000.00
PETS income_statement (annual, 2023-03-31) — Other Gand A: 41714000.00
PETS income_statement (annual, 2023-03-31) — Other Income Expense: 944000.00
PETS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 860000.00
PETS balance_sheet (annual, 2023-03-31) — Other Inventories: 19023000.00
PETS balance_sheet (annual, 2023-03-31) — Other Investments: 5000000.00
PETS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 3825000.00
PETS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 944000.00
PETS balance_sheet (annual, 2023-03-31) — Payables: 52701000.00
PETS balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 57512000.00
PETS balance_sheet (annual, 2023-03-31) — Preferred Shares Number: 3000.00
PETS balance_sheet (annual, 2023-03-31) — Preferred Stock: 9000.00
PETS balance_sheet (annual, 2023-03-31) — Preferred Stock Equity: 9000.00
PETS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 863000.00
PETS income_statement (annual, 2023-03-31) — Pretax Income: 7445000.00
PETS balance_sheet (annual, 2023-03-31) — Properties: 0.00
PETS cash_flow (annual, 2023-03-31) — Purchase Of Business: -5000000.00
PETS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -5260000.00
PETS balance_sheet (annual, 2023-03-31) — Receivables: 1740000.00
PETS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 171068000.00
PETS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 3546000.00
PETS balance_sheet (annual, 2023-03-31) — Retained Earnings: 91659000.00
PETS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 25190000.00
PETS income_statement (annual, 2023-03-31) — Selling General And Administration: 66904000.00
PETS balance_sheet (annual, 2023-03-31) — Share Issued: 21084277.00
PETS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 6617000.00
PETS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 109966000.00
PETS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 109097000.00
PETS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
PETS income_statement (annual, 2023-03-31) — Tax Provision: 2305000.00
PETS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.31
PETS balance_sheet (annual, 2023-03-31) — Total Assets: 167478000.00
PETS balance_sheet (annual, 2023-03-31) — Total Capitalization: 109966000.00
PETS balance_sheet (annual, 2023-03-31) — Total Debt: 0.00
PETS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 109966000.00
PETS income_statement (annual, 2023-03-31) — Total Expenses: 241518000.00
PETS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 57512000.00
PETS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 37047000.00
PETS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
PETS income_statement (annual, 2023-03-31) — Total Operating Income As Reported: 6051000.00
PETS income_statement (annual, 2023-03-31) — Total Other Finance Cost: -450000.00
PETS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 26231000.00
PETS balance_sheet (annual, 2023-03-31) — Working Capital: 72919000.00
PETS income_statement (annual, 2024-03-31) — +Operating Expense: 92930000.00
PETS income_statement (annual, 2024-03-31) — +Total Revenue: 274095000.00
PETS balance_sheet (annual, 2024-03-31) — Accounts Payable: 37024000.00
PETS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 3283000.00
PETS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -20128000.00
PETS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 25146000.00
PETS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -273000.00
PETS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 2000000.00
PETS cash_flow (annual, 2024-03-31) — Amortization Of Intangibles: 2000000.00
PETS cash_flow (annual, 2024-03-31) — Asset Impairment Charge: 324000.00
PETS income_statement (annual, 2024-03-31) — Basic Average Shares: 20395959.00
PETS income_statement (annual, 2024-03-31) — Basic EPS: -0.37
PETS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 104086000.00
PETS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 19510000.00
PETS cash_flow (annual, 2024-03-31) — Capital Expenditure: -4511000.00
PETS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 1454000.00
PETS balance_sheet (annual, 2024-03-31) — Capital Stock: 30000.00
PETS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 55296000.00
PETS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 55296000.00
PETS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -12437000.00
PETS cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: -12437000.00
PETS cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -40670000.00
PETS cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: 4317000.00
PETS cash_flow (annual, 2024-03-31) — Change In Account Payable: 6102000.00
PETS cash_flow (annual, 2024-03-31) — Change In Accrued Expense: 276000.00
PETS cash_flow (annual, 2024-03-31) — Change In Income Tax Payable: -1101000.00
PETS cash_flow (annual, 2024-03-31) — Change In Inventory: -6417000.00
PETS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 788000.00
PETS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -766000.00
PETS cash_flow (annual, 2024-03-31) — Change In Other Working Capital: -390000.00
PETS cash_flow (annual, 2024-03-31) — Change In Payable: 5001000.00
PETS cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: 5277000.00
PETS cash_flow (annual, 2024-03-31) — Change In Prepaid Assets: 490000.00
PETS cash_flow (annual, 2024-03-31) — Change In Receivables: -1742000.00
PETS cash_flow (annual, 2024-03-31) — Change In Tax Payable: -1101000.00
PETS cash_flow (annual, 2024-03-31) — Change In Working Capital: -2760000.00
PETS cash_flow (annual, 2024-03-31) — Changes In Account Receivables: -1742000.00
PETS cash_flow (annual, 2024-03-31) — Changes In Cash: -48790000.00
PETS balance_sheet (annual, 2024-03-31) — Common Stock: 21000.00
PETS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 96722000.00
PETS income_statement (annual, 2024-03-31) — Cost Of Revenue: 189327000.00
PETS balance_sheet (annual, 2024-03-31) — Current Accrued Expenses: 5452000.00
PETS balance_sheet (annual, 2024-03-31) — Current Assets: 93648000.00
PETS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 459000.00
PETS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 459000.00
PETS balance_sheet (annual, 2024-03-31) — Current Deferred Liabilities: 2603000.00
PETS balance_sheet (annual, 2024-03-31) — Current Deferred Revenue: 2603000.00
PETS balance_sheet (annual, 2024-03-31) — Current Liabilities: 72158000.00
PETS cash_flow (annual, 2024-03-31) — Deferred Income Tax: 292000.00
PETS cash_flow (annual, 2024-03-31) — Deferred Tax: 292000.00
PETS cash_flow (annual, 2024-03-31) — Depreciation: 5200000.00
PETS cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 7056000.00
PETS income_statement (annual, 2024-03-31) — Depreciation Amortization Depletion Income Statement: 7056000.00
PETS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 7056000.00
PETS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 7056000.00
PETS income_statement (annual, 2024-03-31) — Diluted Average Shares: 20395959.00
PETS income_statement (annual, 2024-03-31) — Diluted EPS: -0.37
PETS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -7464000.00
PETS balance_sheet (annual, 2024-03-31) — Dividends Payable: 1466000.00
PETS income_statement (annual, 2024-03-31) — EBIT: -8162000.00
PETS income_statement (annual, 2024-03-31) — EBITDA: -1106000.00
PETS cash_flow (annual, 2024-03-31) — End Cash Position: 55296000.00
PETS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -12437000.00
PETS cash_flow (annual, 2024-03-31) — Free Cash Flow: -194000.00
PETS income_statement (annual, 2024-03-31) — General And Administrative Expense: 55246000.00
PETS balance_sheet (annual, 2024-03-31) — Goodwill: 26658000.00
PETS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 37861000.00
PETS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 3556000.00
PETS balance_sheet (annual, 2024-03-31) — Gross PPE: 48217000.00
PETS income_statement (annual, 2024-03-31) — Gross Profit: 84768000.00
PETS cash_flow (annual, 2024-03-31) — Income Tax Paid Supplemental Data: 130000.00
PETS balance_sheet (annual, 2024-03-31) — Inventory: 28556000.00
PETS balance_sheet (annual, 2024-03-31) — Invested Capital: 96722000.00
PETS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -40670000.00
PETS balance_sheet (annual, 2024-03-31) — Investments And Advances: 5300000.00
PETS balance_sheet (annual, 2024-03-31) — Land And Improvements: 3700000.00
PETS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 995000.00
PETS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 995000.00
PETS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 23575000.00
PETS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -36159000.00
PETS income_statement (annual, 2024-03-31) — Net Income: -7464000.00
PETS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -7464000.00
PETS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -7464000.00
PETS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -7464000.00
PETS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -7464000.00
PETS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -7464000.00
PETS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -7464000.00
PETS income_statement (annual, 2024-03-31) — Net Interest Income: 511000.00
PETS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 511000.00
PETS balance_sheet (annual, 2024-03-31) — Net PPE: 28089000.00
PETS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -4511000.00
PETS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 58870000.00
PETS balance_sheet (annual, 2024-03-31) — Non Current Deferred Assets: 4986000.00
PETS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 4986000.00
PETS income_statement (annual, 2024-03-31) — Normalized EBITDA: -1106000.00
PETS income_statement (annual, 2024-03-31) — Normalized Income: -7464000.00
PETS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 4317000.00
PETS income_statement (annual, 2024-03-31) — Operating Income: -8162000.00
PETS income_statement (annual, 2024-03-31) — Operating Revenue: 274095000.00
PETS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 21148692.00
PETS balance_sheet (annual, 2024-03-31) — Other Current Assets: 6325000.00
PETS income_statement (annual, 2024-03-31) — Other Gand A: 55246000.00
PETS income_statement (annual, 2024-03-31) — Other Income Expense: 1378000.00
PETS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 11203000.00
PETS balance_sheet (annual, 2024-03-31) — Other Inventories: 28556000.00
PETS balance_sheet (annual, 2024-03-31) — Other Investments: 5300000.00
PETS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 1378000.00
PETS balance_sheet (annual, 2024-03-31) — Other Properties: 1432000.00
PETS balance_sheet (annual, 2024-03-31) — Payables: 63644000.00
PETS balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 69096000.00
PETS balance_sheet (annual, 2024-03-31) — Preferred Shares Number: 3000.00
PETS balance_sheet (annual, 2024-03-31) — Preferred Stock: 9000.00
PETS balance_sheet (annual, 2024-03-31) — Preferred Stock Equity: 9000.00
PETS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 188000.00
PETS income_statement (annual, 2024-03-31) — Pretax Income: -6273000.00
PETS balance_sheet (annual, 2024-03-31) — Properties: 0.00
PETS cash_flow (annual, 2024-03-31) — Purchase Of Business: -36159000.00
PETS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -4511000.00
PETS balance_sheet (annual, 2024-03-31) — Receivables: 3283000.00
PETS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 189327000.00
PETS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 7056000.00
PETS balance_sheet (annual, 2024-03-31) — Retained Earnings: 71555000.00
PETS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 30628000.00
PETS income_statement (annual, 2024-03-31) — Selling General And Administration: 85874000.00
PETS balance_sheet (annual, 2024-03-31) — Share Issued: 21148692.00
PETS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 6869000.00
PETS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 96731000.00
PETS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 58861000.00
PETS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
PETS income_statement (annual, 2024-03-31) — Tax Provision: 1191000.00
PETS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.21
PETS balance_sheet (annual, 2024-03-31) — Total Assets: 169884000.00
PETS balance_sheet (annual, 2024-03-31) — Total Capitalization: 96731000.00
PETS balance_sheet (annual, 2024-03-31) — Total Debt: 1454000.00
PETS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 96731000.00
PETS income_statement (annual, 2024-03-31) — Total Expenses: 282257000.00
PETS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 73153000.00
PETS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 76236000.00
PETS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 995000.00
PETS income_statement (annual, 2024-03-31) — Total Operating Income As Reported: -8162000.00
PETS income_statement (annual, 2024-03-31) — Total Other Finance Cost: -511000.00
PETS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 25154000.00
PETS balance_sheet (annual, 2024-03-31) — Working Capital: 21490000.00
PETS income_statement (quarterly, 2024-09-30) — +Operating Expense: 18219000.00
PETS income_statement (quarterly, 2024-09-30) — +Total Revenue: 58044000.00
PETS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 16951000.00
PETS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 1620000.00
PETS balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 17515000.00
PETS balance_sheet (quarterly, 2024-09-30) — Allowance For Doubtful Accounts Receivable: -27000.00
PETS cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 34000.00
PETS income_statement (quarterly, 2024-09-30) — Basic EPS: 0.11
PETS cash_flow (quarterly, 2024-09-30) — Beginning Cash Position: 45992000.00
PETS cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -1265000.00
PETS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 1214000.00
PETS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 30000.00
PETS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 52045000.00
PETS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 52045000.00
PETS cash_flow (quarterly, 2024-09-30) — Cash Dividends Paid: -71000.00
PETS cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Financing Activities: -71000.00
PETS cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Investing Activities: -1265000.00
PETS cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Operating Activities: 7389000.00
PETS cash_flow (quarterly, 2024-09-30) — Change In Account Payable: -7513000.00
PETS cash_flow (quarterly, 2024-09-30) — Change In Accrued Expense: 284000.00
PETS cash_flow (quarterly, 2024-09-30) — Change In Income Tax Payable: -1675000.00
PETS cash_flow (quarterly, 2024-09-30) — Change In Inventory: 12428000.00
PETS cash_flow (quarterly, 2024-09-30) — Change In Other Current Assets: 110000.00
PETS cash_flow (quarterly, 2024-09-30) — Change In Other Current Liabilities: -107000.00
PETS cash_flow (quarterly, 2024-09-30) — Change In Other Working Capital: -496000.00
PETS cash_flow (quarterly, 2024-09-30) — Change In Payable: -9188000.00
PETS cash_flow (quarterly, 2024-09-30) — Change In Payables And Accrued Expense: -8904000.00
PETS cash_flow (quarterly, 2024-09-30) — Change In Prepaid Assets: -171000.00
PETS cash_flow (quarterly, 2024-09-30) — Change In Receivables: 608000.00
PETS cash_flow (quarterly, 2024-09-30) — Change In Tax Payable: -1675000.00
PETS cash_flow (quarterly, 2024-09-30) — Change In Working Capital: 3468000.00
PETS cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: 608000.00
PETS cash_flow (quarterly, 2024-09-30) — Changes In Cash: 6053000.00
PETS balance_sheet (quarterly, 2024-09-30) — Common Stock: 21000.00
PETS cash_flow (quarterly, 2024-09-30) — Common Stock Dividend Paid: -71000.00
PETS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 96425000.00
PETS income_statement (quarterly, 2024-09-30) — Cost Of Revenue: 39271000.00
PETS balance_sheet (quarterly, 2024-09-30) — Current Accrued Expenses: 5412000.00
PETS balance_sheet (quarterly, 2024-09-30) — Current Assets: 70779000.00
PETS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 446000.00
PETS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 446000.00
PETS balance_sheet (quarterly, 2024-09-30) — Current Deferred Liabilities: 1650000.00
PETS balance_sheet (quarterly, 2024-09-30) — Current Deferred Revenue: 1650000.00
PETS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 48832000.00
PETS cash_flow (quarterly, 2024-09-30) — Deferred Income Tax: -670000.00
PETS cash_flow (quarterly, 2024-09-30) — Deferred Tax: -670000.00
PETS cash_flow (quarterly, 2024-09-30) — Depreciation Amortization Depletion: 1658000.00
PETS income_statement (quarterly, 2024-09-30) — Depreciation Amortization Depletion Income Statement: 1658000.00
PETS cash_flow (quarterly, 2024-09-30) — Depreciation And Amortization: 1658000.00
PETS income_statement (quarterly, 2024-09-30) — Depreciation And Amortization In Income Statement: 1658000.00
PETS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 20938817.00
PETS income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.11
PETS income_statement (quarterly, 2024-09-30) — Diluted NI Availto Com Stockholders: 2326000.00
PETS income_statement (quarterly, 2024-09-30) — EBIT: 554000.00
PETS income_statement (quarterly, 2024-09-30) — EBITDA: 2212000.00
PETS cash_flow (quarterly, 2024-09-30) — End Cash Position: 52045000.00
PETS cash_flow (quarterly, 2024-09-30) — Financing Cash Flow: -71000.00
PETS cash_flow (quarterly, 2024-09-30) — Free Cash Flow: 6124000.00
PETS income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 10492000.00
PETS balance_sheet (quarterly, 2024-09-30) — Goodwill: 26658000.00
PETS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 36882000.00
PETS balance_sheet (quarterly, 2024-09-30) — Gross Accounts Receivable: 1647000.00
PETS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 27392000.00
PETS income_statement (quarterly, 2024-09-30) — Gross Profit: 18773000.00
PETS income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
PETS cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 385000.00
PETS income_statement (quarterly, 2024-09-30) — Interest Income: 185000.00
PETS income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: 185000.00
PETS balance_sheet (quarterly, 2024-09-30) — Inventory: 13092000.00
PETS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 96425000.00
PETS cash_flow (quarterly, 2024-09-30) — Investing Cash Flow: -1265000.00
PETS balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 5300000.00
PETS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 768000.00
PETS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 768000.00
PETS cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: 0.00
PETS income_statement (quarterly, 2024-09-30) — Net Income: 2326000.00
PETS income_statement (quarterly, 2024-09-30) — Net Income Common Stockholders: 2326000.00
PETS income_statement (quarterly, 2024-09-30) — Net Income Continuous Operations: 2326000.00
PETS income_statement (quarterly, 2024-09-30) — Net Income From Continuing And Discontinued Operation: 2326000.00
PETS income_statement (quarterly, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: 2326000.00
PETS cash_flow (quarterly, 2024-09-30) — Net Income From Continuing Operations: 2326000.00
PETS income_statement (quarterly, 2024-09-30) — Net Income Including Noncontrolling Interests: 2326000.00
PETS income_statement (quarterly, 2024-09-30) — Net Interest Income: 185000.00
PETS income_statement (quarterly, 2024-09-30) — Net Non Operating Interest Income Expense: 185000.00
PETS balance_sheet (quarterly, 2024-09-30) — Net PPE: 27392000.00
PETS cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: -1265000.00
PETS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 59552000.00
PETS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Assets: 5681000.00
PETS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 5681000.00
PETS income_statement (quarterly, 2024-09-30) — Normalized EBITDA: 2212000.00
PETS income_statement (quarterly, 2024-09-30) — Normalized Income: 2326000.00
PETS cash_flow (quarterly, 2024-09-30) — Operating Cash Flow: 7389000.00
PETS income_statement (quarterly, 2024-09-30) — Operating Income: 554000.00
PETS income_statement (quarterly, 2024-09-30) — Operating Revenue: 58044000.00
PETS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 20663218.00
PETS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 3655000.00
PETS income_statement (quarterly, 2024-09-30) — Other Gand A: 10492000.00
PETS income_statement (quarterly, 2024-09-30) — Other Income Expense: 186000.00
PETS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 10224000.00
PETS balance_sheet (quarterly, 2024-09-30) — Other Investments: 5300000.00
PETS income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 186000.00
PETS balance_sheet (quarterly, 2024-09-30) — Other Properties: 27392000.00
PETS balance_sheet (quarterly, 2024-09-30) — Payables: 41324000.00
PETS balance_sheet (quarterly, 2024-09-30) — Payables And Accrued Expenses: 46736000.00
PETS balance_sheet (quarterly, 2024-09-30) — Preferred Shares Number: 3000.00
PETS balance_sheet (quarterly, 2024-09-30) — Preferred Stock: 9000.00
PETS balance_sheet (quarterly, 2024-09-30) — Preferred Stock Equity: 9000.00
PETS balance_sheet (quarterly, 2024-09-30) — Prepaid Assets: 367000.00
PETS income_statement (quarterly, 2024-09-30) — Pretax Income: 925000.00
PETS cash_flow (quarterly, 2024-09-30) — Purchase Of Business: 0.00
PETS cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: -1265000.00
PETS balance_sheet (quarterly, 2024-09-30) — Receivables: 1620000.00
PETS income_statement (quarterly, 2024-09-30) — Reconciled Cost Of Revenue: 39271000.00
PETS income_statement (quarterly, 2024-09-30) — Reconciled Depreciation: 1658000.00
PETS balance_sheet (quarterly, 2024-09-30) — Retained Earnings: 78889000.00
PETS income_statement (quarterly, 2024-09-30) — Selling And Marketing Expense: 6069000.00
PETS income_statement (quarterly, 2024-09-30) — Selling General And Administration: 16561000.00
PETS balance_sheet (quarterly, 2024-09-30) — Share Issued: 20663218.00
PETS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
PETS cash_flow (quarterly, 2024-09-30) — Stock Based Compensation: 573000.00
PETS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 96434000.00
PETS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 59543000.00
PETS income_statement (quarterly, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
PETS income_statement (quarterly, 2024-09-30) — Tax Provision: -1401000.00
PETS income_statement (quarterly, 2024-09-30) — Tax Rate For Calcs: 0.21
PETS balance_sheet (quarterly, 2024-09-30) — Total Assets: 146034000.00
PETS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 96434000.00
PETS balance_sheet (quarterly, 2024-09-30) — Total Debt: 1214000.00
PETS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 96434000.00
PETS income_statement (quarterly, 2024-09-30) — Total Expenses: 57490000.00
PETS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 49600000.00
PETS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 75255000.00
PETS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 768000.00
PETS income_statement (quarterly, 2024-09-30) — Total Operating Income As Reported: 554000.00
PETS income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: -185000.00
PETS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 24373000.00
PETS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
PETS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
PETS balance_sheet (quarterly, 2024-09-30) — Working Capital: 21947000.00
PETS income_statement (quarterly, 2024-12-31) — +Operating Expense: 16581000.00
PETS income_statement (quarterly, 2024-12-31) — +Total Revenue: 51961000.00
PETS balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 10945000.00
PETS balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 2259000.00
PETS balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 17967000.00
PETS balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -88000.00
PETS cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 148000.00
PETS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 20634651.00
PETS income_statement (quarterly, 2024-12-31) — Basic EPS: -0.03
PETS cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 52045000.00
PETS cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -777000.00
PETS balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 1105000.00
PETS balance_sheet (quarterly, 2024-12-31) — Capital Stock: 30000.00
PETS balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 50101000.00
PETS balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 50101000.00
PETS cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: -1000.00
PETS cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -1000.00
PETS cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -777000.00
PETS cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -1166000.00
PETS cash_flow (quarterly, 2024-12-31) — Change In Account Payable: -6007000.00
PETS cash_flow (quarterly, 2024-12-31) — Change In Accrued Expense: 2977000.00
PETS cash_flow (quarterly, 2024-12-31) — Change In Income Tax Payable: 110000.00
PETS cash_flow (quarterly, 2024-12-31) — Change In Inventory: 1297000.00
PETS cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: 110000.00
PETS cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: -109000.00
PETS cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: -494000.00
PETS cash_flow (quarterly, 2024-12-31) — Change In Payable: -5897000.00
PETS cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: -2920000.00
PETS cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: -206000.00
PETS cash_flow (quarterly, 2024-12-31) — Change In Receivables: -788000.00
PETS cash_flow (quarterly, 2024-12-31) — Change In Tax Payable: 110000.00
PETS cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -3110000.00
PETS cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -788000.00
PETS cash_flow (quarterly, 2024-12-31) — Changes In Cash: -1944000.00
PETS balance_sheet (quarterly, 2024-12-31) — Common Stock: 21000.00
PETS balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 96175000.00
PETS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 35830000.00
PETS balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 10922000.00
PETS balance_sheet (quarterly, 2024-12-31) — Current Assets: 68383000.00
PETS balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 453000.00
PETS balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 453000.00
PETS balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 1156000.00
PETS balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 1156000.00
PETS balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 47959000.00
PETS cash_flow (quarterly, 2024-12-31) — Deferred Income Tax: 465000.00
PETS cash_flow (quarterly, 2024-12-31) — Deferred Tax: 465000.00
PETS cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 1586000.00
PETS income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 1586000.00
PETS cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 1586000.00
PETS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 1586000.00
PETS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 20634651.00
PETS income_statement (quarterly, 2024-12-31) — Diluted EPS: -0.03
PETS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -707000.00
PETS income_statement (quarterly, 2024-12-31) — EBIT: -450000.00
PETS income_statement (quarterly, 2024-12-31) — EBITDA: 1136000.00
PETS cash_flow (quarterly, 2024-12-31) — End Cash Position: 50101000.00
PETS cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -1000.00
PETS cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -1943000.00
PETS income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 10786000.00
PETS balance_sheet (quarterly, 2024-12-31) — Goodwill: 26658000.00
PETS balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 36393000.00
PETS balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 2347000.00
PETS balance_sheet (quarterly, 2024-12-31) — Gross PPE: 29502000.00
PETS income_statement (quarterly, 2024-12-31) — Gross Profit: 16131000.00
PETS income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
PETS cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 8000.00
PETS income_statement (quarterly, 2024-12-31) — Interest Income: 28000.00
PETS income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 28000.00
PETS balance_sheet (quarterly, 2024-12-31) — Inventory: 11795000.00
PETS balance_sheet (quarterly, 2024-12-31) — Invested Capital: 96175000.00
PETS cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -777000.00
PETS balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 5300000.00
PETS balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 652000.00
PETS balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 652000.00
PETS cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
PETS income_statement (quarterly, 2024-12-31) — Net Income: -707000.00
PETS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -707000.00
PETS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -707000.00
PETS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -707000.00
PETS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -707000.00
PETS cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -707000.00
PETS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -707000.00
PETS income_statement (quarterly, 2024-12-31) — Net Interest Income: 28000.00
PETS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 28000.00
PETS balance_sheet (quarterly, 2024-12-31) — Net PPE: 29502000.00
PETS cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -777000.00
PETS balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 59791000.00
PETS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 5217000.00
PETS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 5217000.00
PETS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 1136000.00
PETS income_statement (quarterly, 2024-12-31) — Normalized Income: -707000.00
PETS cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -1166000.00
PETS income_statement (quarterly, 2024-12-31) — Operating Income: -450000.00
PETS income_statement (quarterly, 2024-12-31) — Operating Revenue: 51961000.00
PETS balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 20656457.00
PETS balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 3888000.00
PETS income_statement (quarterly, 2024-12-31) — Other Gand A: 10786000.00
PETS income_statement (quarterly, 2024-12-31) — Other Income Expense: 180000.00
PETS balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 9735000.00
PETS balance_sheet (quarterly, 2024-12-31) — Other Investments: 5300000.00
PETS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 180000.00
PETS balance_sheet (quarterly, 2024-12-31) — Other Properties: 29502000.00
PETS balance_sheet (quarterly, 2024-12-31) — Payables: 35428000.00
PETS balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 46350000.00
PETS balance_sheet (quarterly, 2024-12-31) — Preferred Shares Number: 3000.00
PETS balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 9000.00
PETS balance_sheet (quarterly, 2024-12-31) — Preferred Stock Equity: 9000.00
PETS balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 340000.00
PETS income_statement (quarterly, 2024-12-31) — Pretax Income: -242000.00
PETS cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
PETS cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -777000.00
PETS balance_sheet (quarterly, 2024-12-31) — Receivables: 2259000.00
PETS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 35830000.00
PETS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 1586000.00
PETS balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 78187000.00
PETS income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 4209000.00
PETS income_statement (quarterly, 2024-12-31) — Selling General And Administration: 14995000.00
PETS balance_sheet (quarterly, 2024-12-31) — Share Issued: 20656457.00
PETS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
PETS cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 452000.00
PETS balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 96184000.00
PETS balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 59782000.00
PETS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
PETS income_statement (quarterly, 2024-12-31) — Tax Provision: 465000.00
PETS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.21
PETS balance_sheet (quarterly, 2024-12-31) — Total Assets: 144795000.00
PETS balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 96184000.00
PETS balance_sheet (quarterly, 2024-12-31) — Total Debt: 1105000.00
PETS balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 96184000.00
PETS income_statement (quarterly, 2024-12-31) — Total Expenses: 52411000.00
PETS balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 48611000.00
PETS balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 76412000.00
PETS balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 652000.00
PETS income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -450000.00
PETS income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: -28000.00
PETS balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 24483000.00
PETS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
PETS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
PETS balance_sheet (quarterly, 2024-12-31) — Working Capital: 20424000.00
PETS income_statement (annual, 2025-03-31) — Basic Average Shares: 20596022.00
PETS income_statement (annual, 2025-03-31) — Basic EPS: -0.30
PETS income_statement (annual, 2025-03-31) — Diluted Average Shares: 20596022.00
PETS income_statement (annual, 2025-03-31) — Diluted EPS: -0.30
PETS income_statement (annual, 2025-03-31) — Total Other Finance Cost: -185000.00
PETS income_statement (quarterly, 2025-06-30) — +Operating Expense: 21277000.00
PETS income_statement (quarterly, 2025-06-30) — +Total Revenue: 51180000.00
PETS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 20041000.00
PETS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1605000.00
PETS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 19123000.00
PETS balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -223000.00
PETS cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 27252000.00
PETS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 20755416.00
PETS income_statement (quarterly, 2025-06-30) — Basic EPS: -1.65
PETS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 54720000.00
PETS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1292000.00
PETS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 883000.00
PETS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 30000.00
PETS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 41127000.00
PETS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 41127000.00
PETS cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -1000.00
PETS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -30000.00
PETS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1292000.00
PETS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -12271000.00
PETS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -3523000.00
PETS cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -1287000.00
PETS cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: 151000.00
PETS cash_flow (quarterly, 2025-06-30) — Change In Inventory: -2156000.00
PETS cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 112000.00
PETS cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -113000.00
PETS cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -977000.00
PETS cash_flow (quarterly, 2025-06-30) — Change In Payable: -3372000.00
PETS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -4659000.00
PETS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -1170000.00
PETS cash_flow (quarterly, 2025-06-30) — Change In Receivables: 718000.00
PETS cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: 151000.00
PETS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -8245000.00
PETS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 718000.00
PETS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -13593000.00
PETS balance_sheet (quarterly, 2025-06-30) — Common Stock: 21000.00
PETS cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -1000.00
PETS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 51537000.00
PETS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 36777000.00
PETS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 10900000.00
PETS balance_sheet (quarterly, 2025-06-30) — Current Assets: 67892000.00
PETS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 469000.00
PETS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 469000.00
PETS balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1108000.00
PETS balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 1108000.00
PETS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 57616000.00
PETS cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 0.00
PETS cash_flow (quarterly, 2025-06-30) — Deferred Tax: 0.00
PETS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2283000.00
PETS income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 2283000.00
PETS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2283000.00
PETS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 2283000.00
PETS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 20755416.00
PETS income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.65
PETS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -34152000.00
PETS income_statement (quarterly, 2025-06-30) — EBIT: -6874000.00
PETS income_statement (quarterly, 2025-06-30) — EBITDA: -4591000.00
PETS cash_flow (quarterly, 2025-06-30) — End Cash Position: 41127000.00
PETS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -30000.00
PETS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -13563000.00
PETS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 12948000.00
PETS balance_sheet (quarterly, 2025-06-30) — Goodwill: 0.00
PETS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 6956000.00
PETS balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 1828000.00
PETS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 29690000.00
PETS income_statement (quarterly, 2025-06-30) — Gross Profit: 14403000.00
PETS income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 27258000.00
PETS balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 104000.00
PETS balance_sheet (quarterly, 2025-06-30) — Inventory: 18361000.00
PETS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 51537000.00
PETS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1292000.00
PETS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 5300000.00
PETS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 414000.00
PETS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 414000.00
PETS income_statement (quarterly, 2025-06-30) — Net Income: -34152000.00
PETS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -34152000.00
PETS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -34152000.00
PETS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -34152000.00
PETS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -34152000.00
PETS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -34152000.00
PETS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -34152000.00
PETS income_statement (quarterly, 2025-06-30) — Net Interest Income: -198000.00
PETS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -198000.00
PETS cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -29000.00
PETS balance_sheet (quarterly, 2025-06-30) — Net PPE: 29690000.00
PETS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1292000.00
PETS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 44590000.00
PETS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 263000.00
PETS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 263000.00
PETS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 22667000.00
PETS income_statement (quarterly, 2025-06-30) — Normalized Income: -12618180.00
PETS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -12271000.00
PETS income_statement (quarterly, 2025-06-30) — Operating Income: -6874000.00
PETS income_statement (quarterly, 2025-06-30) — Operating Revenue: 51180000.00
PETS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 20835210.00